Pacific Wealth Strategies Group’s AbbVie ABBV Stock Holding History

Pacific Wealth Strategies Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.04M	Buy	8,096 +5,045	+165%	+$1.09M	1.17%	27
2026 Q1	$664K	Buy	3,051 +1,086	+55%	+$241K	0.41%	41
2025 Q4	$449K	Buy	1,965 +1,010	+106%	+$230K	0.25%	41
2025 Q3	$221K	Buy	+955	New	+$194K	0.14%	58
2022 Q2	–	Sell	-10,795	Closed	-$1.75M	–	46
2022 Q1	$1.75M	Hold	10,795	–	–	0.73%	31
2021 Q4	$1.46M	Buy	10,795 +1,393	+15%	+$165K	0.51%	44
2021 Q3	$1.01M	Buy	9,402 +147	+2%	+$16.8K	0.38%	53
2021 Q2	$1.04M	Buy	9,255 +214	+2%	+$24.1K	0.4%	54
2021 Q1	$978K	Buy	9,041 +3,108	+52%	+$332K	0.41%	55
2020 Q4	$636K	Buy	5,933 +3,372	+132%	+$324K	0.27%	63
2020 Q3	$224K	Buy	+2,561	New	+$241K	0.12%	69

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pacific Wealth Strategies Group's ABBV Position: Q2 2026 in Review

Pacific Wealth Strategies Group increased its AbbVie (ABBV) stake by 165% in Q2 2026, buying an estimated $1.09M and bringing the position to 8,096 shares worth $2.04M. The position accounts for 1.17% of the portfolio, ranked #27.

Pacific Wealth Strategies Group first reported a position in ABBV in Q3 2020 and has held it in 11 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Pacific Wealth Strategies Group held 8,096 shares of AbbVie worth $2.04M as of Q2 2026.
Pacific Wealth Strategies Group bought 5,045 AbbVie shares in Q2 2026, an estimated $1.09M.
AbbVie made up 1.17% of Pacific Wealth Strategies Group's portfolio in Q2 2026, its #27 holding.
Pacific Wealth Strategies Group first reported a position in AbbVie in Q3 2020 and has held it in 11 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pacific Wealth Strategies Group's 13F filing for Q2 2026, filed 17 Jul 2026.